Authors
Imran K. Tailor, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi ArabiaFollow
Nawal F. Alshehry, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
Syed Z. Zaidi, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
Mohammed A. Marei, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
Ibraheem H. Motabi, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
Mansour Alfayez, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
Syed Y. Altaf, Department of Adult Hematology and Bone Marrow Transplantation, King Fahad Medical City, Riyadh, Saudi Arabia
Abstract
No abstract for this article type.
Recommended Citation
Tailor, Imran K.; Alshehry, Nawal F.; Zaidi, Syed Z.; Marei, Mohammed A.; Motabi, Ibraheem H.; Alfayez, Mansour; and Altaf, Syed Y.
(2023)
"Outcome of myeloma patients with COVID-19 on active lenalidomide-based therapy: Does lenalidomide protect from severe COVID-19?,"
Hematology/Oncology and Stem Cell Therapy: Vol. 16
:
Iss.
1
, Article 10.
Available at: https://doi.org/10.1016/j.hemonc.2020.08.002
DOWNLOADS
Since January 10, 2023
COinS
